Literature DB >> 23805601

Association of CD8 T cells with depression and anxiety in patients with liver cirrhosis.

Fang-Yuan Ko1, Shih-Jen Tsai, Albert C Yang, Yang Zhou, Lie-Ming Xu.   

Abstract

OBJECTIVE: Depression and anxiety frequently co-occur in patients with. cirrhosis, but their underlying biological substrates are unclear. There is now evidence to suggest that depression is accompanied by signs of an immune response. This study investigated the correlation between depression/anxiety and T-lymphocyte subsets in liver cirrhosis patients.
METHODS: A total of 59 patients (37 males and 22 females; aged between 26-81 years) with cirrhosis were enrolled in the study. Severity of depression and anxiety were assessed through the Hamilton depressive scale (HAMD, the 24-item version) and the Hamilton anxiety scale (HAMA). T-lymphocyte subsets (CD3, CD4, and CD8) in peripheral blood were determined by flow cytometry. The relationship between lymphocyte subsets and depression/anxiety scores was studied by correlation analysis.
RESULTS: The mean total HAMD and HAMA scores for the 59 subjects were 12.8 +/- 10.4 (range = 0-46) and 7.0 +/- 5.7 (range = 0-26), respectively. Fourteen of 59 subjects (23.7%) had HAMD scores equal to or above 20, indicative of depression. The percentage of CD8, but not CD3 or CD4, in T-lymphocyte subsets was positively correlated with depression (HAMD) (r = 0.268, P = 0.043) and anxiety severity (HAMA) (r = 0.321, P = 0.013). After controlling for age and Child-Pugh scores, the correlations were still significant.
CONCLUSION: Around one-fourth of cirrhosis patients may have depression, although depression is not related to cirrhosis severity. Our findings are the first to show that depression and anxiety may be associated with increased levels of CD8 in T-lymphocyte subsets in cirrhosis patients, suggesting that an imbalance of T-lymphocyte subsets may be a factor facilitating depression and anxiety in cirrhotic patients. Examination of CD8 T-lymphocytes may prove useful in assessing the potential relationship between depression, anxiety, immunity, and liver cirrhosis.

Entities:  

Mesh:

Year:  2013        PMID: 23805601     DOI: 10.2190/PM.45.1.b

Source DB:  PubMed          Journal:  Int J Psychiatry Med        ISSN: 0091-2174            Impact factor:   1.210


  5 in total

1.  Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.

Authors:  Laura Grosse; Livia A Carvalho; Tom K Birkenhager; Witte J Hoogendijk; Steven A Kushner; Hemmo A Drexhage; Veerle Bergink
Journal:  Psychopharmacology (Berl)       Date:  2015-05-08       Impact factor: 4.530

2.  Anxiety and depressive disorders among patients with esophageal cancer in Taiwan: a nationwide population-based study.

Authors:  Li-Yu Hu; Fan-Chen Ku; Yen-Po Wang; Cheng-Che Shen; Yu-Wen Hu; Chiu-Mei Yeh; Pan-Ming Chen; Huey-Ling Chiang; Ti Lu; Tzeng-Ji Chen; Chung-Jen Teng; Chia-Jen Liu
Journal:  Support Care Cancer       Date:  2014-09-02       Impact factor: 3.603

3.  Delayed diapedesis of CD8 T cells contributes to long-term pathology after ischemic stroke in male mice.

Authors:  Uma Maheswari Selvaraj; Thomas A Ujas; Xiangmei Kong; Ashwani Kumar; Erik J Plautz; Shanrong Zhang; Chao Xing; Tiffany L Sudduth; Donna M Wilcock; Jadwiga Turchan-Cholewo; Mark P Goldberg; Ann M Stowe
Journal:  Brain Behav Immun       Date:  2021-05-05       Impact factor: 19.227

4.  Correlation between anxiety-depression symptoms and immune characteristics in inpatients with 2019 novel coronavirus in Wuhan, China.

Authors:  Congchong Wu; Zhiying Zhou; Li Ni; Jiang Cao; Meifang Tan; Xiu Wu; Yi Xu; Jianbo Hu
Journal:  J Psychiatr Res       Date:  2021-07-15       Impact factor: 4.791

5.  Rheumatoid arthritis and the risk of bipolar disorder: a nationwide population-based study.

Authors:  Chih-Chao Hsu; San-Chi Chen; Chia-Jen Liu; Ti Lu; Cheng-Che Shen; Yu-Wen Hu; Chiu-Mei Yeh; Pan-Ming Chen; Tzeng-Ji Chen; Li-Yu Hu
Journal:  PLoS One       Date:  2014-09-17       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.